Federal antitrust enforcement is entering a period of uncertainty in the second Trump administration. It is an open question what priorities Andrew Ferguson, the newly-appointed Federal Trade Commission (FTC) Chair, and Gail...more
The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. In this week's Report: FDA issues...more
Read the latest news on antitrust, competition and economic regulation (ACER) in this Spring's edition of our quarterly ACER newsletter.
...more
7/17/2019
/ ACPERA ,
Antitrust Provisions ,
AT&T ,
Competition ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
FinTech ,
FRAND ,
Health Care Providers ,
Hospitals ,
Leniency Programs ,
Pharmaceutical Industry ,
Public Procurement Policies ,
Regulatory Standards ,
Sherman Act ,
Total Cost of Care Model (TCOC) ,
Whistleblowers
FTC takes another look at merger remedies -
On 3 February 2017, the U.S. Federal Trade Commission (“FTC”) released its Merger Remedies Study, which analyzed the success of merger remedies imposed by the FTC from 2006 to...more
2/23/2017
/ Africa ,
Anti-Monopoly ,
Antitrust Provisions ,
Best Practices ,
Cartels ,
China ,
COMESA ,
Competition ,
Department of Justice (DOJ) ,
EU ,
European Commission ,
Extradition ,
Federal Trade Commission (FTC) ,
Gun-Jumping ,
Hart-Scott-Rodino Act ,
Hong Kong ,
Human Resources Professionals ,
Hungary ,
INTERPOL ,
Merger Controls ,
Mexico ,
MOFCOM ,
NRDC ,
PEMEX ,
Pharmaceutical Industry ,
Pre-Merger Filing Requirements ,
Railways ,
Red Notices ,
Regulatory Oversight ,
Remedies ,
Resale Pricing ,
Retail Market ,
Settlement ,
Transportation Industry ,
Trump Administration ,
UK